TRUEinvivo® is pleased to announce that the patent for the DOSEmapper™ TLD bead strings and Automated DOSEmapper™ TLD Reader was granted in the EU on 6th January 2021. The patent number is EP3341754. This reinforces the first patent grant which was in the USA back in January 2020. The company has further patents pending in key large countries which have high numbers of radiotherapy cancer treatment centres.
DOSEmapper™ & Automated Reader Patent Granted in the EU
Share This Story, Choose Your Platform!
About the Author: Nigel Biggs
Nigel is the COO of TRUEinvivo. He was a software engineer before founding Pixology plc. which provided in-store and online picture ordering systems worldwide in the new era of digital photography including the first in-camera correction of red eyes. Pixology floated on AIM in 2003 and Nigel left in 2006 to start Passionate Innovation Ltd. He also became the visiting Entrepreneur-in-Residence at the University of Surrey where he met Shakar Jafari in 2015. Nigel was a consultant to another medical devices company before joining TRUEinvivo.
Leave A Comment
You must be logged in to post a comment.